Header

UZH-Logo

Maintenance Infos

Passive immunization against oral AIDS virus transmission: an approach to prevent mother-to-infant HIV-1 transmission?


Hofmann-Lehmann, Regina; Rasmussen, Robert A; Vlasak, J; Smith, B A; Baba, T W; Liska, V; Montefiori, D C; McClure, H M; Anderson, D C; Bernacky, B J; Rizvi, T A; Schmidt, R; Hill, L R; Keeling, M E; Katinger, H; Stiegler, G; Posner, M R; Cavacini, L A; Chou, T C; Ruprecht, Ruth M (2001). Passive immunization against oral AIDS virus transmission: an approach to prevent mother-to-infant HIV-1 transmission? Journal of Medical Primatology, 30(4):190-196.

Abstract

To develop immunoprophylaxis regimens against mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission, we established a simian-human immunodeficiency virus (SHIV) model in neonatal macaques that mimics intrapartum mucosal virus exposure (T.W. Baba, J. Koch, E.S. Mittler et al: AIDS Res Hum Retroviruses 10:351-357, 1994). We protected four neonates from oral SHIV-vpu+ challenge by ante- and postpartum treatment with a synergistic triple combination of immunoglobulin (Ig) G1 human anti-HIV-1 neutralizing monoclonal antibodies (mAbs) (T.W. Baba, V. Liska, R. Hofmann-Lehmann et al: Nature Med 6:200-206, 2000), which recognize the CD4-binding site of Env, a glycosylation-dependent gp120, or a linear gp41 epitope. Two neonates that received only postpartum mAbs were also protected from oral SHIV-vpu+ challenge, indicating that postpartum treatment alone is sufficient. Next, we evaluated a similar mAb combination against SHIV89.6P, which encodes env of primary HIV89.6. One of four mAb-treated neonates was protected from infection and two maintained normal CD4+ T-cell counts. We conclude that the epitopes recognized by the three mAbs are important determinants for achieving protection. Combination immunoprophylaxis with synergistic mAbs seems promising to prevent maternal HIV-1 transmission in humans.

Abstract

To develop immunoprophylaxis regimens against mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission, we established a simian-human immunodeficiency virus (SHIV) model in neonatal macaques that mimics intrapartum mucosal virus exposure (T.W. Baba, J. Koch, E.S. Mittler et al: AIDS Res Hum Retroviruses 10:351-357, 1994). We protected four neonates from oral SHIV-vpu+ challenge by ante- and postpartum treatment with a synergistic triple combination of immunoglobulin (Ig) G1 human anti-HIV-1 neutralizing monoclonal antibodies (mAbs) (T.W. Baba, V. Liska, R. Hofmann-Lehmann et al: Nature Med 6:200-206, 2000), which recognize the CD4-binding site of Env, a glycosylation-dependent gp120, or a linear gp41 epitope. Two neonates that received only postpartum mAbs were also protected from oral SHIV-vpu+ challenge, indicating that postpartum treatment alone is sufficient. Next, we evaluated a similar mAb combination against SHIV89.6P, which encodes env of primary HIV89.6. One of four mAb-treated neonates was protected from infection and two maintained normal CD4+ T-cell counts. We conclude that the epitopes recognized by the three mAbs are important determinants for achieving protection. Combination immunoprophylaxis with synergistic mAbs seems promising to prevent maternal HIV-1 transmission in humans.

Statistics

Citations

Dimensions.ai Metrics
27 citations in Web of Science®
33 citations in Scopus®
30 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

0 downloads since deposited on 05 Dec 2016
0 downloads since 12 months

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:05 Vetsuisse Faculty > Veterinary Clinic > Department of Farm Animals
Dewey Decimal Classification:570 Life sciences; biology
630 Agriculture
Date:August 2001
Deposited On:05 Dec 2016 13:11
Last Modified:19 Feb 2018 22:10
Publisher:Wiley-Blackwell Publishing, Inc.
ISSN:0047-2565
OA Status:Closed
Publisher DOI:https://doi.org/10.1034/j.1600-0684.2001.d01-52.x
PubMed ID:11555137

Download